Frontier Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,443
| Closed | -$3.41M | – | 307 |
|
|
2025
Q1 | $3.41M | Buy |
53,443
+17,881
| +50% | +$1.14M | 0.04% | 267 |
|
|
2024
Q4 | $4.32M | Sell |
35,562
-4,735
| -12% | -$576K | 0.04% | 259 |
|
|
2024
Q3 | $5.03M | Sell |
40,297
-902
| -2% | -$113K | 0.05% | 250 |
|
|
2024
Q2 | $6.51M | Sell |
41,199
-33,998
| -45% | -$5.37M | 0.06% | 238 |
|
|
2024
Q1 | $9.73M | Buy |
75,197
+22,570
| +43% | +$2.92M | 0.09% | 219 |
|
|
2023
Q4 | $5.07M | Sell |
52,627
-8,544
| -14% | -$824K | 0.05% | 232 |
|
|
2023
Q3 | $7.42M | Sell |
61,171
-48,149
| -44% | -$5.84M | 0.08% | 208 |
|
|
2023
Q2 | $12.5M | Sell |
109,320
-119,823
| -52% | -$13.7M | 0.12% | 182 |
|
|
2023
Q1 | $31.6M | Sell |
229,143
-32,555
| -12% | -$4.49M | 0.33% | 117 |
|
|
2022
Q4 | $33.9M | Sell |
261,698
-22,252
| -8% | -$2.88M | 0.37% | 106 |
|
|
2022
Q3 | $31.4M | Sell |
283,950
-164,130
| -37% | -$18.1M | 0.37% | 100 |
|
|
2022
Q2 | $33.6M | Sell |
448,080
-45,916
| -9% | -$3.44M | 0.39% | 98 |
|
|
2022
Q1 | $38.6M | Sell |
493,996
-60,327
| -11% | -$4.71M | 0.35% | 105 |
|
|
2021
Q4 | $49.9M | Sell |
554,323
-78,356
| -12% | -$7.06M | 0.39% | 86 |
|
|
2021
Q3 | $58.5M | Buy |
632,679
+17,099
| +3% | +$1.58M | 0.46% | 73 |
|
|
2021
Q2 | $47.9M | Buy |
+615,580
| New | +$47.9M | 0.35% | 111 |
|
|
2018
Q2 | – | Sell |
-228,640
| Closed | -$16.9M | – | 326 |
|
|
2018
Q1 | $16.9M | Buy |
+228,640
| New | +$16.9M | 0.12% | 205 |
|